Clinical Laserthermia Systems AB (CLSB)

Now, when summer is approaching and we’re all looking forward to enjoying some days off, we have sumarized the news from the first half of 2024. In recent times, we have achieved great success in our neurology segment. The limited market launch in the US of the ClearPoint® Prism system, powered by CLS, has been successful and a new product, Prism Bone Anchor, which increases the addressable market significantly, has been launched by our partner ClearPoint Neuro Inc. At the same time, the first clinical data have been presented, and new partnerships have been established within the urology segment. We wish all our shareholders, collaboration partners, clinicians & patients a great summer! Read the full newsletter here: https://lnkd.in/dh_9v_Jk #cls #laserablation #focallaserablation

We are happy to announce that the recruitment of glioblastoma patients to the CLS-sponsored clinical study at Skåne University Hospital is completed. Professor Peter Siesjö, principal investigator of the study comments, "The treatment system used for surgical intervention and navigation in the MR camera worked excellently in the completed clinical study. The benefits are obvious for the patients with less invasive interventions and shorter treatment times. For the healthcare system, the method provides the opportunity to offer treatment in cases where conventional surgery is not possible or suitable". Read more here: https://lnkd.in/d4sxMyBR #cls #laserablation #focallaserablation

We are happy to announce that CLS has received an additional order from ClearPoint Neuro, Inc. The order is for ClearPoint Prism products and is part of ClearPoint Neuro's full market launch in North America, which began in early June this year, and follows previous orders. Read more here: https://lnkd.in/dbmdQrE3 #cls #laserablation #focallaserablation

The Business Update presentation held yesterday, June 12, by our CEO Dan J Mogren and Chairman of the Board Hans von Celsing, is now available on request: https://lnkd.in/dZk8B7eE #cls #laserablation #focallaserablation

Today marks the first day of Nordkongress Urologie in Lübeck. We are thrilled that the first clinical data from the investigator-initiated study at the University Hospital Magdeburg using the CLS’s Ultrasound-Guided TRANBERG® Thermal Therapy system for Focal Laser Ablation (FLA) of localized prostate cancer has been accepted for oral presentation during the meeting. Read more about the Nordkongress Urologie here: https://lnkd.in/embQUXhX Read more about the press release here: https://lnkd.in/gSqnNCYg #focallaser #focallaserablation #cls #NordkongressUrologie

Thank you Dr.Sijo Parekattil M.D., FACS, and the entire team at Avant Concierge Urology, for providing this incredible insight into using the CLS TRANBERG system for prostate cancer treatment. We are thrilled to see that we are making a difference in patient care together! #laserablation #focallaserablation #CLS

Clinical Laserthermia Systems welcomes investors, media, and the public to virtually attend a Live Business Update Event on June 12, 2024 at 9.30.   During the event, the company will give an update on the recently announced strategic focus on neurosurgery. Special focus will be given to the commercial launch of the ClearPoint Prism product offering in the US, together with ClearPoint Neuro.   Following the completion of the presentation, viewers will have the opportunity to ask questions through the webcast video chat.   The presentation will be held by Dan Mogren, CEO and Hans von Celsing, Chairman of Clinical Laserthermia. Systems. Sign up here: https://lnkd.in/dZk8B7eE #cls #laserablation #focallaserablation

Following our participation at #ASSFN2024 (American Society of Stereotactic and Functional Neurosurgery's) Annual Congress, together with ClearPoint Neuro, Inc., we can conclude that our product offering has clear advantages against competition from world-leading companies in the market. CLS adds unique and essential elements to the complete treatment system for neurosurgery, which is now being fully launched in the US." Read more in our press release here: https://lnkd.in/d6rf2z9S #cls #laserablation #focallaserablation

We are delighted to share a snapshot from our time at the Tour de L’HBP 2024 conference in Bordeaux, France, with Eric Girard, CEO of MTEC, proudly representing our CLS TRANBERG® system. Thank you, Eric, and the entire MTEC team, we look forward to our continued collaboration. Together we are driving advancements to bring the TRANBERG system for Focal Laser Ablation (FLA) to more prostate cancer patients in France! #Focallaser #Focallaserablation #TourDeLHBP2024 #Bordeaux #MTEC

#ASSFN2024 is a key scientific event within neurosurgery and this year our partner ClearPoint Neuro, Inc. has big news to present including the latest updates on ClearPoint Prism, powered by CLS. #cls #laserablation #focallaserablation